
eHealth, Inc.: updates and filings
Price
$0.39
November 18, 2026Market cap $12M
What Ploutos Investor adds for eHealth
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 44% since Nov 4, 2026, when the 10-Q these figures come from was filed ($0.63 then, $0.35 on Nov 17, 2026). The figures date from before that move.10-Q
- The reported profit is far larger than a business usually earns on its market value, which usually means one-off or accounting gains. We leave out the P/E and the earnings yield.
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 4, 2026next Feb 4, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
October 2026
August 2026
May 2026
February 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 12, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 4, 2026Results of operationsForm8-K
- Oct 16, 2026Delisting noticeForm8-K
- Aug 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 5, 2026Shares registered for employeesFormS-8
- Aug 5, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 4, 2026Results of operationsForm8-K
- Jul 28, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jun 25, 2026Officer or director change, shareholder voteForm8-K
- May 14, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- May 7, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 6, 2026Results of operations, officer or director changeForm8-K
- Apr 28, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 28, 2026Additional annual meeting materialFormDEFA14A
- Apr 28, 2026Annual meeting proxy statementFormDEF 14A
- Apr 10, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 31, 2026Officer or director changeForm8-K
- Feb 26, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 25, 2026Results of operationsForm8-K
- Feb 17, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 17, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jan 6, 2026Material agreement entered, material agreement ended, new material financial obligation, change to shareholders' rights, amended articles or bylaws, Regulation FD disclosureForm8-K
- Dec 18, 2025Amended articles or bylaws, Regulation FD disclosureForm8-K
- Dec 4, 2025Letter from the SECFormUPLOAD
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 12, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 5, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 4, 2026 | 8-K | Results of operations | Document |
| Oct 16, 2026 | 8-K | Delisting notice | Document |
| Aug 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 5, 2026 | S-8 | Shares registered for employees | Document |
| Aug 5, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 4, 2026 | 8-K | Results of operations | Document |
| Jul 28, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jun 25, 2026 | 8-K | Officer or director change, shareholder vote | Document |
| May 14, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| May 7, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 6, 2026 | 8-K | Results of operations, officer or director change | Document |
| Apr 28, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 28, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 28, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Apr 10, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 31, 2026 | 8-K | Officer or director change | Document |
| Feb 26, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 25, 2026 | 8-K | Results of operations | Document |
| Feb 17, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 17, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jan 6, 2026 | 8-K | Material agreement entered, material agreement ended, new material financial obligation, change to shareholders' rights, amended articles or bylaws, Regulation FD disclosure | Document |
| Dec 18, 2025 | 8-K | Amended articles or bylaws, Regulation FD disclosure | Document |
| Dec 4, 2025 | UPLOAD | Letter from the SEC | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Apr 25, 2006.
The full analysis
What do eHealth's filings show?
The filings are where every one of eHealth's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.